Program of the 2nd International Workshop on Waldenström's macroglobulinemia

September 26-30, 2002
Athens, Greece

Download the entire program as a word document
Choose a Day
1 - 2 - 3 - 4

7:00 AM

Breakfast

8:00 AM

Dr. Anderson (USA)

Targeting plasma cell dyscrasias in their bone marrow microenvironment

8:15 AM

Drs. Stein/Nichols (USA)#

BCL-2 antisense therapy in WM

8:30 AM

Dr. Frankel (USA)

BCL-2 antisense therapy of WM: A targeted approach to enhance efficacy

8:45 AM

Dr. Dhodapkar (USA)

Dendritic cell mediated immunotherapy of WM

9:00 AM

Dr. C. Mitsiades (USA)

Novel biologically based therapies for WM

9:15 AM

Dr. Al-Katib (USA)

WM-WSU SCID mouse model: Utility in developing new therapeutic strategies in WM

9:30-10:00

Dr. Anderson (USA)

Panel Discussion

10:00-10:15

Session Break

10:15 AM

Dr. Stone (USA)

Monoclonal macroglobulins with antibody activity

10:30 AM

Dr. Fermand (France)

Macroglobulinemia with symptomatic auto-antibody activity: How to treat?

10:45 AM

Dr. Pestronk (USA)

Antigenic targets of serum IgM in WM and IgM MGUS

11:00 AM

Dr. Levine (USA)

Treatment of IgM related neuropathies

11:15 AM

Dr. Gertz (USA)

Amyloidosis with IgM monoclonal gammopathies

11:30-12:00

Dr. Stone (USA)

Panel Discussion

12:00-1:15

Lunch

1:15-2:45

Dr. Gertz (USA)

Report of Consensus Panel Three on Treatment Recommendations in WM

Dr. Treon (USA)

Discussion and Consensus Summary

2:45-3:15

Session Break

3:15 PM

Dr. Blade (Spain)

Applying Myeloma response criteria to WM

3:30-5:00

Dr. Kimby (USA)

Report of Consensus Panel Four on Uniform Response Criteria in WM

Dr. Weber (USA)

Discussion and Consensus Summary

6:30 PM

Bus Departures for Closing Ceremonies and Farewell Reception at the Museum of the National and Kapodistrian University of Athens

*Young Investigator Fellowship Award Recipient
Sponsored by the International Waldenström's Macroglobulinemia Foundation

# Smokler Research Grant recipient
Sponsored by the RFW, Ltd.